IJPR  articles are Indexed in SCOPUS (2010 - 2021)Click Here     *Five Years Citation in Google scholar (2016 - 2020) is. 1451*        Now IJPR is Q2 in SJR Ranking     Scopus Coverage of IJPR (2010-2021 Issue 1)            

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Herbal Approach and Its Molecular Hypothesis for the Management of Convulsant Induced Depression as Comorbidity: A Critical Review

Author: SUNITI CHAND, AVIJIT MAZUMDER, SAUMYA DAS, ANAMIKA SHARMA, ANKIT SHARMA, LALIT KUMAR, ROHITASH RATHOUR
Abstract: Epilepsy is a psychiatric chronic disease characterised via the repeatedly occurrence of epileptic seizures that are episodic and unpredictable. It is often related to brain disorders that contribute to many behavioural comorbidities, such as depressive disorders (DDs), Parkinson. There is a high prevalence of depressive disorder in epileptic patients. A population-based research has found that 29% of epileptic patients suffer from depression, As compared to 8.7% of healthy individuals. A recent research has also shown that a history of depression is associated with a 4 to 6 times higher risk of epilepsy development. Epileptic induced depression remains fragile. It is largely unclear how epilepsy affects the neuronal functions of depressants in the brain. Among the scores of molecules extensively expressed by depression induced via epilepsy, inflammatory cytokine, (IL-1ß), (IL-6), (TNF-a) are found to demonstrate a very significant induction. Controlled trials are urgently required due to inadequate evidence on pharmacological antidepressant management in epileptics. Epilepsy induced depression significantly limits the living. To enhance the quality of life of patients, treatment for epilepsy induced depression is therefore extremely necessary. To date, multiple phytochemicals, herbal formulations and plant extraction is able to manage comorbidity between epilepsy and depression due to their potential phytoconstituent hitting directly to the responsible molecular target. And this can be a great alternative or translational therapy that can prevent the development and worsening of comorbidity between epilepsy and depression.
Keyword: Epilepsy, Depression, Inflammatory cytokine, (IL-1ß), (IL-6)
DOI: https://doi.org/10.31838/ijpr/2021.13.02.049
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free